atezolizumab,nivolumab,ipilimumab,Pembrolizumab
merck,roche,bms
['renal,(-adrenal)']
a discussion about the adjuvant trials in renal cancer at #esmo22 - where did it all go wrong? 
Interested in Urology Cancers, biomarkers and drug development.